Skip to main content
  • Home
  • HealthEdge Investment Partners
Institutional profile

HealthEdge Investment Partners

HealthEdge Investment Partners is a lower-middle-market private equity firm focused exclusively on healthcare businesses.

Official website

  • Healthcare and life sciences private equity investment firm
  • Healthcare & Life Sciences PEF
  • Tier III

Overview

HealthEdge Investment Partners is a lower-middle-market private equity firm focused exclusively on healthcare businesses. It invests in founder-led and established companies where operating experience and healthcare relationships can support growth.

Smaller healthcare businesses frequently need more than transaction capital. They may require stronger financial systems, management depth, commercial strategy, compliance infrastructure, technology investment, and a disciplined approach to acquisitions. Within The Economy Wiki, the firm is connected to the Healthcare & Life Sciences PEF market category.

Firm facts

InstitutionHealthEdge Investment Partners
TypeHealthcare and life sciences private equity investment firm
HeadquartersTampa, United States
Founded2005
Primary ranking focusHealthcare & Life Sciences PEF
Highest 2026 tierTier III

Activities and investment capabilities

HealthEdge’s focused mandate allows it to work closely with management teams through these institutionalization steps. Its portfolio reflects the role of specialist investors in subsectors that are too small or operationally specific for larger funds.

Healthcare investing

Equity investment across healthcare services, products and technology.

Life sciences exposure

Capital for pharmaceutical, biotechnology, medtech and outsourced-service platforms.

Sector value creation

Support informed by regulation, reimbursement, clinical workflows and market access.

Strategy and transaction coverage

Strategy and sector coverage

Healthcare services; life sciences; pharmaceuticals; medtech; diagnostics; healthcare IT

Transaction and ownership contexts

Buyouts; growth investments; recapitalizations; platform formation; add-on acquisitions

Market position

HealthEdge Investment Partners fits Tier III because it is a long-standing healthcare-only investor with a hands-on lower-middle-market model and a clearly defined role within the specialist segment.

HealthEdge Investment Partners is assessed within the Healthcare & Life Sciences PEF framework. For wider market context, see The Mid-Market Advantage in Healthcare Private Equity.

Competitive context

HealthEdge Investment Partners is recognized Tier III in Top 30 Healthcare & Life Sciences PEF 2026. The ranking compares firms by institutional relevance, specialist capability, investment activity, operating depth and market positioning. Comparable-firm links below support navigation and do not imply that every institution competes for every transaction or asset.

Leadership and governance

Leadership, investment-committee composition and operating resources may change over time. Current information should be confirmed through HealthEdge Investment Partners’s official website.

Leadership areaCurrent source
Investment and operating leadershipCurrent team and governance information

Corporate and public information

This profile refers to HealthEdge Investment Partners as the public-facing investment organization. Individual funds, management companies, advisers and regulated entities may use separate legal names across jurisdictions.

Corporate and disclosure information
OrganizationHealthEdge Investment Partners
HeadquartersTampa, United States
Public websitehealthedgepartners.com
Profile basisPublic institutional information and Capital Ranking editorial research

Ranking recognition

Related Economy analysis

Selected Economy Markets articles provide context for the investment, diligence, financing and value-creation themes relevant to this firm:

Sources

  1. HealthEdge Investment Partners — official website
  2. Capital Ranking — Top 30 Healthcare & Life Sciences PEF 2026

First published: 28 August 2026

Last reviewed: 28 August 2026

Profile scope: Healthcare & Life Sciences PEF

This page is an editorial reference and does not constitute investment, legal or regulatory advice.